Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2013 · fourth_quarter · 4@
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY 2014; Provisions regarding National Institutes of Health funding.
Source: Senate LDA
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Diagnostic Innovation Testing and Knowledge Advancement Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Medical Testing Availability Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Medical Testing Availability Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Medical Testing Availability Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 845: Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (The SHIELD Act); Provisions regarding patent litigation reform. S. 1013: Patent Abuse Reduction Act of 2013; Provisions regarding patent litigation reform. House and Senate Judiciary Discussion Drafts; Provisions regarding patent litigation reform.
Patent Abuse Reduction Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 845: Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (The SHIELD Act); Provisions regarding patent litigation reform. S. 1013: Patent Abuse Reduction Act of 2013; Provisions regarding patent litigation reform. House and Senate Judiciary Discussion Drafts; Provisions regarding patent litigation reform.
Justice for All Reauthorization Act of 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S. 822: Justice for All Reauthorizatio Act of 2013: Provisions regarding Debbie Smith DNA backlog.
SAFER Act of 2012
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act; Provisions regarding DNA testing.
SAFER Act of 2012
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act; Provisions regarding DNA testing.
Federal Buildings Personnel Training Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act; Provisions regarding DNA testing.
Federal Buildings Personnel Training Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act; Provisions regarding DNA testing.
Affordable Tutoring of Our Children Act
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S. 744: Border Security, Economic Opportunity, and Immigration Modernization Act; Provisions regarding DNA amendments.
Affordable Tutoring of Our Children Act
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S. 744: Border Security, Economic Opportunity, and Immigration Modernization Act; Provisions regarding DNA amendments.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft regulation regarding Unique Device Identification System: Provisions regarding FDA requirements for medical device labeling.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S. 1599: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Provisions regarding National Institutes of Health funding. S. 2375/H.R. 5973: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013; Provisions regarding FDA funding.
End Big Oil Tax Subsidies Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.601/S.517/S. 250: Katie Sepich Enhanced DNA Collection Act of 2012 and Justice for All Reauthorization Act of 2012; All provisions of the bills; Katie Sepich Act amendment to S. 250.
Katie Sepich Enhanced DNA Collection Act of 2012
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.6014/S.517/S. 250: Katie Sepich Enhanced DNA Collection Act of 2012 and Justice for All Reauthorization Act of 2012; All provisions of the bills; Katie Sepich Act amendment to S. 250. H.R. 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act of 2012; Provisions regarding DNA testing.
SAFER Act of 2012
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.6014/S.517/S. 250: Katie Sepich Enhanced DNA Collection Act of 2012 and Justice for All Reauthorization Act of 2012; All provisions of the bills; Katie Sepich Act amendment to S. 250. H.R. 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act of 2012; Provisions regarding DNA testing.
Katie Sepich Enhanced DNA Collection Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.988/S.517and revision not yet numbered: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.
Katie Sepich Enhanced DNA Collection Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.988/S.517and revision not yet numbered: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.
Patent Continuing Disclosure Act
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.1249/S.23: America Invents Act; Provisions regarding false markings, virtual marking first to file, post grant review, and inequitable conduct. H.R.1056: Patent Continuing Disclosure Act; All provisions.
Patent Continuing Disclosure Act
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R. 1056: Patent Continuing Disclosure Act; All provisions of the bill. H.R. 1249: Leahy-Smith America Invents Act; Provisions regarding false markings, virtual marking first to file, post grant review and inequitable conduct.
Further Additional Continuing Appropriations Amendments, 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY12 (No Bill Number to date); Provisions regarding National Institutes of Health funding. H.R. 1363: Department of Defense and Further Additional Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and U.S. Food and Drug Administration funding. H.R. 1473: Department of Defense and Full Year Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and U.S. Food and Drug Administration funding, biosurveillance programs and appropriations for forensic DNA.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
Katie Sepich Enhanced DNA Collection Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.988/ S.517: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions.
Katie Sepich Enhanced DNA Collection Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.988/S.517and revision not yet numbered: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.
Katie Sepich Enhanced DNA Collection Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.988/ S.517: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.
Katie Sepich Enhanced DNA Collection Act of 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.988/S.517and revision not yet numbered: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.
Making further continuing appropriations for fiscal year 2011, and for other purposes.
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
Making further continuing appropriations for fiscal year 2011, and for other purposes.
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515: PATENT REFORM ACT OF 2009; SENATE MANAGERS AMENDMENT; PROVISIONS REGARDING DAMAGES, INEQUITABLE CONDUCT, RESEARCH USE EXEMPTION AND POST GRANT REVIEW.
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515: Patent Reform Act of 2009; Senate Managers Amendment; Provisions regarding damages, inequitable conduct, research use exemption, post grant review and false markings. HR 4954: To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings; Provisions regarding false markings.
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.1260/S.515: Patent Reform Act of 2009; Senate Managers Amendment; Provisions regarding damages, inequitable conduct, research use exemption, post grant review and false markings. H.R.4954: To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings; Provisions regarding false markings.
Katie Sepich Enhanced DNA Collection Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.4614/ S.3805: Katie Sepich Enhanced DNA Collection Act of 2010; All provisions. S.3842: Justice for all Reauthorization Act of 2010; Provisions regarding Forensic DNA.
Katie Sepich Enhanced DNA Collection Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 4614: Katie Sepich Enhanced DNA Collection Act of 2010; Forensic DNA policy.
Katie Sepich Enhanced DNA Collection Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.4614/ S.3805: Katie Sepich Enhanced DNA Collection Act of 2010; All provisions. S.3842/ House unnumbered companion: Justice for all Reauthorization Act of 2010; Provisions regarding Forensic DNA.
Katie Sepich Enhanced DNA Collection Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 4614: KATIE SEPICH ENHANCED DNA COLLECTION ACT OF 2010; FORENSIC DNA POLICY.
To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings.
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515: Patent Reform Act of 2009; Senate Managers Amendment; Provisions regarding damages, inequitable conduct, research use exemption, post grant review and false markings. HR 4954: To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings; Provisions regarding false markings.
To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings.
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.1260/S.515: Patent Reform Act of 2009; Senate Managers Amendment; Provisions regarding damages, inequitable conduct, research use exemption, post grant review and false markings. H.R.4954: To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings; Provisions regarding false markings.
To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings.
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.4954/S.515: To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings; Provisions regarding false markings.
Weapons of Mass Destruction Prevention and Preparedness Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S 1649/HR 5057: Weapons of Mass Destruction Prevention and Preparedness Act of 2010; Provisions regarding biosecurity.
Genomics and Personalized Medicine Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 5440: Genomics and Personalized Medicine Act of 2010; Provisions regarding personalized medicine.
Department of Homeland Security Appropriations Act, 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
Fiscal Year 2011 Departments of Labor and Health and Human Services Appropriations; Provisions regarding National Institutes of Health funding and CURES Acceleration Network (No Bill Number yet assigned). Fiscal Year 2011 Budget Resolution; Provisions regarding National Institutes of Health funding (No Bill Number yet assigned). S 1298/HR 2892: Department of Homeland Security Appropriations Act, 2010; Provisions regarding biosurveillance programs. Fiscal Year 2011 Commerce, Justice and Science Appropriations; Provisions regarding appropriations for forensic DNA (No Bill Number yet assigned).
WMD Prevention and Preparedness Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S 1649: WEAPONS OF MASS DESTRUCTION PREVENTION AND PREPAREDNESS ACT OF 2009; PROVISIONS REGARDING BIOSECURITY.
WMD Prevention and Preparedness Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S 1649/HR 5057: Weapons of Mass Destruction Prevention and Preparedness Act of 2010; Provisions regarding biosecurity.
Department of Homeland Security Appropriations Act, 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
Department of Homeland Security Appropriations Act, 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. H.R.3081: Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. S.3636/House unnumbered companion: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2011; Provisions regarding appropriations for Forensic DNA.
Commerce, Justice, Science, and Related Agencies Appropriations Act, 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. H.R.3081: Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. S.3636/House unnumbered companion: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2011; Provisions regarding appropriations for Forensic DNA.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. H.R.3081: Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. S.3636/House unnumbered companion: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2011; Provisions regarding appropriations for Forensic DNA.
Katie Sepich Enhanced DNA Collection Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.4614/ S.3805: Katie Sepich Enhanced DNA Collection Act of 2010; All provisions. S.3842/ House unnumbered companion: Justice for all Reauthorization Act of 2010; Provisions regarding Forensic DNA.
Katie Sepich Enhanced DNA Collection Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.4614/ S.3805: Katie Sepich Enhanced DNA Collection Act of 2010; All provisions. S.3842: Justice for all Reauthorization Act of 2010; Provisions regarding Forensic DNA.
Justice for All Reauthorization Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.4614/ S.3805: Katie Sepich Enhanced DNA Collection Act of 2010; All provisions. S.3842: Justice for all Reauthorization Act of 2010; Provisions regarding Forensic DNA.
Justice for All Reauthorization Act of 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.4614/ S.3805: Katie Sepich Enhanced DNA Collection Act of 2010; All provisions. S.3842/ House unnumbered companion: Justice for all Reauthorization Act of 2010; Provisions regarding Forensic DNA.
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515: Patent Reform Act of 2009; Senate Managers Amendment; Provisions regarding damages, inequitable conduct, research use exemption, post grant review and false markings. HR 4954: To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings; Provisions regarding false markings.
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.4954/S.515: To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings; Provisions regarding false markings.
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515: PATENT REFORM ACT OF 2009; SENATE MANAGERS AMENDMENT; PROVISIONS REGARDING DAMAGES, INEQUITABLE CONDUCT, RESEARCH USE EXEMPTION AND POST GRANT REVIEW.
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
H.R.1260/S.515: Patent Reform Act of 2009; Senate Managers Amendment; Provisions regarding damages, inequitable conduct, research use exemption, post grant review and false markings. H.R.4954: To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings; Provisions regarding false markings.
Family Building Act of 2007
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
Fiscal Year 2011 Departments of Labor and Health and Human Services Appropriations; Provisions regarding National Institutes of Health funding and CURES Acceleration Network (No Bill Number yet assigned). Fiscal Year 2011 Budget Resolution; Provisions regarding National Institutes of Health funding (No Bill Number yet assigned). S 1298/HR 2892: Department of Homeland Security Appropriations Act, 2010; Provisions regarding biosurveillance programs. Fiscal Year 2011 Commerce, Justice and Science Appropriations; Provisions regarding appropriations for forensic DNA (No Bill Number yet assigned).
Fairness for Homeowners Act of 2007
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. H.R.3081: Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. S.3636/House unnumbered companion: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2011; Provisions regarding appropriations for Forensic DNA.
Montgomery GI Bill Degree Extension Act of 2007
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515: PATENT REFORM ACT OF 2009; DAMAGES, INEQUITABLE CONDUCT, RESEARCH USE EXEMPTION
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515 PATENT REFORM ACT OF 2009; DAMAGES, POST GRANT, PATENT AND TRADEMARK OFFICE REFORMS; INEQUITABLE CONDUCT
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515: PATENT REFORM ACT OF 2009; DAMAGES, INEQUITABLE CONDUCT, RESEARCH USE
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515: PATENT REFORM ACT OF 2009; DAMAGES; POST GRANT; PATENT AND TRADEMARK OFFICE REFORMS; INEQUITBALE CONDUCT
Pathway for Biosimilars Act
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT, 2009; NATIONAL INSTITUTES OF HEALTH FUNDING, COMPARATIVE EFFECTIVENESS; NET OPERATING LOSSES TAX PROVISIONS HR 1548: PATHWAY FOR BIOSIMILARS ACT; CREATING A PATHWAY FOR BIOSIMILARS INCLUDING CLINICAL TESTING; NO MANDATORY SUBSTITUTION AT PHARMACY; NEED FOR DIFFERENT NAMES BILL NOT YET INTRODUCED: GENOMICS AND PERSONALIZED MEDICINE ACT; INCENTIVES FOR PERSONALIZED MEDICINE
America's Affordable Health Choices Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S 1796: AMERICA'S HEALTHY FUTURE ACT OF 2009: INTERNATIONAL TAX DEFERRAL CHANGES, MEDICAL DEVICE TAX AND THERAPEUTIC TAX CREDIT HR 3200: AMERICA'S AFFORDBALE HEALTH CHOICES ACT OF 2009; INTERNATIONAL TAX DEFERRAL CHANGES, MEDICAL DEVICE TAX AND THERAPEUTIC TAX CREDIT RESEARCH AND DEVELOPMENT TAX CREDIT--ISSUES RELATED TO CREDIT EXTENSION (NO BILL NUMBER YET ASSIGNED)
America's Affordable Health Choices Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING; AMERICA'S HEALTHY FUTURE ACT OF 2009: BILL NUMBER NOT YET ASSIGNED; FOLLOW ON BIOLOGICS; HR 3200: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009; FOLLOW ON BIOLOGICS HR 3293/SENATE REPORT 111-066: MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING
America's Affordable Health Choices Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
AMERICA'S HEALTHY FUTURE ACT OF 2009: BILL NUMBER NOT YET ASSIGNED; INTERNATIONAL TAX DEFERRAL CHANGES; HR 3200: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009; INTERNATIONAL TAX DEFERRAL CHANGES RESEARCH AND DEVELOPMENT TAX CREDIT--ISSUES RELATED TO CREDIT EXTENSION
America's Affordable Health Choices Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S 1796: AMERICA'S HEALTHY FUTURE ACT OF 2009; FOLLOW ON BIOLOGICS, PUBLIC HEALTH FUNDING, COMPARATIVE EFFECTIVENESS RESEARCH AND TAX PROVISIONS HR 3200: AMERICA'S AFFORDBALE HEALTH CHOICES ACT OF 2009; FOLLOW ON BIOLOGICS, PUBLIC HEALTH FUNDING, COMPARATIVE EFFECTIVENESS RESEARCH AND TAX PROVISIONS
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 2892/S 1298: FISCAL YEAR 2010 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT OF 2009; BIOSURVEILLANCE PROGRAMS; FISCAL YEAR 2011 ADMINISTRATION'S BUDGET REQUEST FOR NATIONAL INSTITUTES OF HEALTH; NATIONAL INSTITUTES OF HEALTH FUNDING (NO BILL YET INTRODUCED) HR 3293/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING; PANDEMIC FLU SURVEILLANCE H2847/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): DEBBIE SMITH DNA FUNDING
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING; HR 2892/S 1298: FISCAL YEAR 2010 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT OF 2009; BIOSURVEILLANCE PROGRAMS; HR 2346: SUPPLEMENTAL APPROPRIATIONS ACT, 2009; PANDEMIC FLU FUNDING, CONTINGENCY FUND DRAWS; HR 2996: DEPARTMENT OF THE INTERIOR, ENVIRONMENT AND RELATED AGENCIES APPROPRIATIONS ACT, 2010; COMPUTATIONAL TOXICOLOGY PROGRAM HR 3293/SENATE REPORT 111-066: MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING; HR 3293/SENATE REPORT 111-066: MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING; AMERICA'S HEALTHY FUTURE ACT OF 2009: BILL NUMBER NOT YET ASSIGNED; FOLLOW ON BIOLOGICS; HR 3200: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009; FOLLOW ON BIOLOGICS HR 3293/SENATE REPORT 111-066: MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING
Justice for Survivors of Sexual Assault Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S. 2736 & HR 4114: JUSTICE FOR SURVIVORS OF SEXUAL ASSAULTS ACT OF 2009; RAPE KIT BACKLOGS ISSUES H2847/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): DEBBIE SMITH DNA FUNDING DNA TESTING LEGISLATION (NO BILL NUMBER YET ASSIGNED)
Supplemental Appropriations Act, 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING AND COMPARATIVE EFFECTIVENESS; NET OPERATING LOSS TAX PROVISIONS; FISCAL YEAR 2010 LABOR, HEALTH AND HUMAN SERVICES APPROPRIATIONS: BILL NOT YET INTRODUCED; NATIONAL INSTITUTES OF HEALTH FUNDING; HR 2892 FISCAL YEAR 2010 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT OF 2009; BIOSURVEILLANCE PROGRAMS; HR 2346 S 1054 SUPPLEMENTAL FISCAL YEAR 2009 APPROPRIATIONS; PANDEMIC FLU FUNDING HR 2996 FISCAL YEAR 2010 ENVIRONMENTAL PROTECTION AGENCY APPROPRIATIONS; FUNDING FOR THE EPA COMPUTATIONAL TOXICOLOGY PROGRAM
Department of Homeland Security Appropriations Act, 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 2892/S 1298: DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT, 2010; BIOSURVEILLANCE PROGRAMS S 1649: WEAPONS OF MASS DESTRUCTION PREVENTION AND PREPAREDNESS ACT OF 2009; BIO SECURITY PROVISIONS
Department of Homeland Security Appropriations Act, 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING; HR 2892/S 1298: FISCAL YEAR 2010 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT OF 2009; BIOSURVEILLANCE PROGRAMS; HR 2346: SUPPLEMENTAL APPROPRIATIONS ACT, 2009; PANDEMIC FLU FUNDING, CONTINGENCY FUND DRAWS; HR 2996: DEPARTMENT OF THE INTERIOR, ENVIRONMENT AND RELATED AGENCIES APPROPRIATIONS ACT, 2010; COMPUTATIONAL TOXICOLOGY PROGRAM HR 3293/SENATE REPORT 111-066: MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING
Department of Homeland Security Appropriations Act, 2010
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 2892/S 1298: FISCAL YEAR 2010 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT OF 2009; BIOSURVEILLANCE PROGRAMS; FISCAL YEAR 2011 ADMINISTRATION'S BUDGET REQUEST FOR NATIONAL INSTITUTES OF HEALTH; NATIONAL INSTITUTES OF HEALTH FUNDING (NO BILL YET INTRODUCED) HR 3293/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING; PANDEMIC FLU SURVEILLANCE H2847/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): DEBBIE SMITH DNA FUNDING
WMD Prevention and Preparedness Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 2892/S 1298: DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT, 2010; BIOSURVEILLANCE PROGRAMS S 1649: WEAPONS OF MASS DESTRUCTION PREVENTION AND PREPAREDNESS ACT OF 2009; BIO SECURITY PROVISIONS
America's Healthy Future Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S 1796: AMERICA'S HEALTHY FUTURE ACT OF 2009: INTERNATIONAL TAX DEFERRAL CHANGES, MEDICAL DEVICE TAX AND THERAPEUTIC TAX CREDIT HR 3200: AMERICA'S AFFORDBALE HEALTH CHOICES ACT OF 2009; INTERNATIONAL TAX DEFERRAL CHANGES, MEDICAL DEVICE TAX AND THERAPEUTIC TAX CREDIT RESEARCH AND DEVELOPMENT TAX CREDIT--ISSUES RELATED TO CREDIT EXTENSION (NO BILL NUMBER YET ASSIGNED)
America's Healthy Future Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S 1796: AMERICA'S HEALTHY FUTURE ACT OF 2009; FOLLOW ON BIOLOGICS, PUBLIC HEALTH FUNDING, COMPARATIVE EFFECTIVENESS RESEARCH AND TAX PROVISIONS HR 3200: AMERICA'S AFFORDBALE HEALTH CHOICES ACT OF 2009; FOLLOW ON BIOLOGICS, PUBLIC HEALTH FUNDING, COMPARATIVE EFFECTIVENESS RESEARCH AND TAX PROVISIONS
Justice for Survivors of Sexual Assault Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S. 2736 & HR 4114: JUSTICE FOR SURVIVORS OF SEXUAL ASSAULTS ACT OF 2009; RAPE KIT BACKLOGS ISSUES H2847/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): DEBBIE SMITH DNA FUNDING DNA TESTING LEGISLATION (NO BILL NUMBER YET ASSIGNED)
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515: PATENT REFORM ACT OF 2009; DAMAGES, INEQUITABLE CONDUCT, RESEARCH USE EXEMPTION
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515 PATENT REFORM ACT OF 2009; DAMAGES, POST GRANT, PATENT AND TRADEMARK OFFICE REFORMS; INEQUITABLE CONDUCT
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515: PATENT REFORM ACT OF 2009; DAMAGES, INEQUITABLE CONDUCT, RESEARCH USE
Patent Reform Act of 2009
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1260/S 515: PATENT REFORM ACT OF 2009; DAMAGES; POST GRANT; PATENT AND TRADEMARK OFFICE REFORMS; INEQUITBALE CONDUCT
Physician Pathology Services Continuity Act of 2007
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT, 2009; NATIONAL INSTITUTES OF HEALTH FUNDING, COMPARATIVE EFFECTIVENESS; NET OPERATING LOSS TAX PROVISIONS BILL NOT YET INTRODUCED: JUSTICE DEPARTMENT APPROPRIATIONS ACT; FUNDING FOR THE DEBBIE SMITH REAUTHORIZATION ACT OF 2008 HR 1105: APPROPRIATIONS ACT, 2009; NATIONAL INSTITUTES OF HEALTH FUNDING; BIODEFENSE FUNDING
To direct the Secretary of Veterans Affairs to establish a process for determining whether a geographic area is sufficiently served by the national cemeteries located in that geographic area.
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING; HR 2892/S 1298: FISCAL YEAR 2010 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT OF 2009; BIOSURVEILLANCE PROGRAMS; HR 2346: SUPPLEMENTAL APPROPRIATIONS ACT, 2009; PANDEMIC FLU FUNDING, CONTINGENCY FUND DRAWS; HR 2996: DEPARTMENT OF THE INTERIOR, ENVIRONMENT AND RELATED AGENCIES APPROPRIATIONS ACT, 2010; COMPUTATIONAL TOXICOLOGY PROGRAM HR 3293/SENATE REPORT 111-066: MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING
Family Building Act of 2007
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 2892/S 1298: DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT, 2010; BIOSURVEILLANCE PROGRAMS S 1649: WEAPONS OF MASS DESTRUCTION PREVENTION AND PREPAREDNESS ACT OF 2009; BIO SECURITY PROVISIONS
Military Retiree Dislocation Assistance Act of 2007
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING; HR 2892/S 1298: FISCAL YEAR 2010 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT OF 2009; BIOSURVEILLANCE PROGRAMS; HR 2346: SUPPLEMENTAL APPROPRIATIONS ACT, 2009; PANDEMIC FLU FUNDING, CONTINGENCY FUND DRAWS; HR 2996: DEPARTMENT OF THE INTERIOR, ENVIRONMENT AND RELATED AGENCIES APPROPRIATIONS ACT, 2010; COMPUTATIONAL TOXICOLOGY PROGRAM HR 3293/SENATE REPORT 111-066: MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING
To authorize appropriations for the U.S. Institute for Environmental Conflict Resolution, and for other purposes.
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
S. 2736 & HR 4114: JUSTICE FOR SURVIVORS OF SEXUAL ASSAULTS ACT OF 2009; RAPE KIT BACKLOGS ISSUES H2847/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): DEBBIE SMITH DNA FUNDING DNA TESTING LEGISLATION (NO BILL NUMBER YET ASSIGNED)
To authorize appropriations for the U.S. Institute for Environmental Conflict Resolution, and for other purposes.
Client: LIFE TECHNOLOGIES CORPORATION · Firm: LIFE TECHNOLOGIES CORPORATION
HR 2892/S 1298: FISCAL YEAR 2010 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT OF 2009; BIOSURVEILLANCE PROGRAMS; FISCAL YEAR 2011 ADMINISTRATION'S BUDGET REQUEST FOR NATIONAL INSTITUTES OF HEALTH; NATIONAL INSTITUTES OF HEALTH FUNDING (NO BILL YET INTRODUCED) HR 3293/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING; PANDEMIC FLU SURVEILLANCE H2847/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): DEBBIE SMITH DNA FUNDING
H.R. 3309: The Innovation Act; Provisions regarding patent litigation reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2013 · fourth_quarter · 4T
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft and final guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only" or "Investigational Use Only"; Provisions regarding FDA regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
H.R. 3309: The Innovation Act; Provisions regarding patent litigation reform.
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY 2014; Provisions regarding National Institutes of Health funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2013 · third_quarter · Q3
S. 744: Border Security, Economic Opportunity, and Immigration Modernization Act; Provisions regarding DNA amendments.
H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests. Draft guidance regarding commercially distributed in vitro diagnostic products labeled "For Research Only or Investigational Use Only:" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.
S. 822: Justice for All Reauthorizatio Act of 2013: Provisions regarding Debbie Smith DNA backlog.
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY 2014; Provisions regarding National Institutes of Health funding.
H.R. 845: Saving High-Tech Innovators from Egregious Legal Disputes Act of 2013 (The SHIELD Act); Provisions regarding patent litigation reform. S. 1013: Patent Abuse Reduction Act of 2013; Provisions regarding patent litigation reform. House and Senate Judiciary Discussion Drafts; Provisions regarding patent litigation reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2013 · second_quarter · Q2
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. No bill numbers to date: BETTER Care Act/Modernizing Laboratory Test Standards for Patients Act of 2011/Medical Testing Availability Act; Provisions regarding lab developed tests.
S. 744: Border Security, Economic Opportunity, and Immigration Modernization Act; Provisions regarding DNA amendments.
HR 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act; Provisions regarding DNA testing.
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2014; Provisions regarding National Institutes of Health funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2013 · first_quarter · Q1
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. No bill numbers to date: BETTER Care Act/Modernizing Laboratory Test Standards for Patients Act of 2011/Medical Testing Availability Act; Provisions regarding lab developed tests.
HR 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act; Provisions regarding DNA testing.
Omnibus Appropriation/CR/S. 1599, Sequestration/implementation of the Budget Control Act of 2011: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2013; Provisions regarding National Institutes of Health funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2012 · fourth_quarter · Q4
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft regulation regarding Unique Device Identification System: Provisions regarding FDA requirements for medical device labeling.
S. 1599, Sequestration/implementation of the Budget Control Act of 2011: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Sequestration/Provisions regarding National Institutes of Health funding. FY 2013 Agriculture Appropriations: Provisions regarding FDA appropriations.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2012 · third_quarter · Q3
S. 1599, sequestration: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Provisions regarding National Institutes of Health funding. FY 2013 Agriculture Appropriations: Provisions regarding FDA appropriations.
Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics. Unique Device Identifier proposed rule; Provisions regarding date format.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2012 · second_quarter · Q2
H.R. 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
S. 1599: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Provisions regarding National Institutes of Health funding. S. 2375/H.R. 5973: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013; Provisions regarding FDA funding.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2012 · first_quarter · Q1
H.R.988/S.517and revision not yet numbered: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.
S. 1599: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Provisions regarding National Institutes of Health funding.
HR 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2011 · fourth_quarter · Q4
HR 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
H.R.988/S.517and revision not yet numbered: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.
S. 1599: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Provisions regarding National Institutes of Health funding. H.R. 2112: Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2012; Provisions regarding FDA funding.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2011 · third_quarter · Q3
S. 1599: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY12; Provisions regarding National Institutes of Health funding. H.R. 2112: Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2012; Provisions regarding FDA funding.
H.R.988/S.517and revision not yet numbered: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.
H.R. 1249: Leahy-Smith American Invents Act; Provisions regarding false markings, virtual marking first to file, post grant review and inequitable conduct.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2011 · second_quarter · Q2
H.R.988/ S.517: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.
H.R. 1056: Patent Continuing Disclosure Act; All provisions of the bill. H.R. 1249: Leahy-Smith America Invents Act; Provisions regarding false markings, virtual marking first to file, post grant review and inequitable conduct.
Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY12 (No Bill Number to date); Provisions regarding National Institutes of Health funding. H.R. 1363: Department of Defense and Further Additional Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and U.S. Food and Drug Administration funding. H.R. 1473: Department of Defense and Full Year Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and U.S. Food and Drug Administration funding, biosurveillance programs and appropriations for forensic DNA.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2011 · first_quarter · Q1
Changes to tax code affecting corporate tax structure and international deferral (No title or bill number to date).
Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, FY12 (No Bill Number to Date); Provisions regarding National Institutes of Health funding. HJRES44/HJRES48: 5th and 6th Continuing Appropriations Resolution, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding. H.R.1/S.Amdt.149: Full Year Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding; biosurveillance programs and appropriations for Forensic DNA.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2010 · fourth_quarter · Q4
H.R.4954/S.515: To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings; Provisions regarding false markings.
H.R.4614/ S.3805: Katie Sepich Enhanced DNA Collection Act of 2010; All provisions. S.3842/ House unnumbered companion: Justice for all Reauthorization Act of 2010; Provisions regarding Forensic DNA.
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. HJRES101/HJRES105/HR3082: 2nd, 3rd and 4th Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health and Food and Drug Administration funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. Omnibus Appropriations Bill (No bill number to date); Possible inclusion of DNA provision.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2010 · third_quarter · Q3
H.R.4614/ S.3805: Katie Sepich Enhanced DNA Collection Act of 2010; All provisions. S.3842: Justice for all Reauthorization Act of 2010; Provisions regarding Forensic DNA.
S.3686/House unnumbered companion: Departments of Labor and Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011; Provisions regarding National Institutes of Health funding and Cures Acceleration Network. H.R.3081: Continuing Appropriations Act, 2011; Provisions regarding National Institutes of Health funding, biosurveillance programs and appropriations for Forensic DNA. S.3607/House unnumbered companion: Department of Homeland Security Appropriations Act, 2011; Provisions regarding biosurveillance programs. S.3636/House unnumbered companion: Commerce, Justice, Science, and Related Agencies Appropriations Act, 2011; Provisions regarding appropriations for Forensic DNA.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2010 · second_quarter · Q2
Fiscal Year 2011 Departments of Labor and Health and Human Services Appropriations; Provisions regarding National Institutes of Health funding and CURES Acceleration Network (No Bill Number yet assigned). Fiscal Year 2011 Budget Resolution; Provisions regarding National Institutes of Health funding (No Bill Number yet assigned). S 1298/HR 2892: Department of Homeland Security Appropriations Act, 2010; Provisions regarding biosurveillance programs. Fiscal Year 2011 Commerce, Justice and Science Appropriations; Provisions regarding appropriations for forensic DNA (No Bill Number yet assigned).
HR 5440: Genomics and Personalized Medicine Act of 2010; Provisions regarding personalized medicine.
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2010 · first_quarter · Q1
HR 3590: PATIENT PROTECTION AND AFFORDABLE CARE ACT / HR 3962: AFFORDABLE HEALTH CARE FOR AMERICA ACT / HR 4872: HEALTH CARE AND EDUCATION RECONCILIATION ACT OF 2010; PROVISIONS REGARDING INTERNATIONAL TAX DEFERRAL CHANGES, MEDICAL DEVICE TAX, AND THERAPEUTIC TAX CREDIT.
FISCAL YEAR 2011 ADMINISTRATION'S BUDGET REQUEST FOR NATIONAL INSTITUTES OF HEALTH. FISCAL YEAR 2011 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT; PROVISIONS REGARDING BIOSURVEILLANCE PROGRAMS (NO BILL NUMBER YET ASSIGNED). FISCAL YEAR 2011 DEPARTMENT'S OF LABOR AND HEALTH AND HUMAN SERVICES APPROPRIATIONS; PROVISIONS REGARDING NATIONAL INSTITUTES OF HEALTH FUNDING AND PANDEMIC FUNDING (NO BILL NUMBER YET ASSIGNED). FISCAL YEAR 2011 BUDGET RESOLUTION; PROVISIONS REGARDING NATIONAL INSTITUTES OF HEALTH FUNDING (NO BILL NUMBER YET ASSIGNED) FISCAL YEAR 2011 COMMERCE, JUSTICE, SCIENCE APPROPRIATIONS; PROVISIONS REGARDING APPROPRIATIONS FOR FORENSIC DNA (NO BILL NUMBER YET ASSIGNED).
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2009 · fourth_quarter · Q4
S 1796: AMERICA'S HEALTHY FUTURE ACT OF 2009: INTERNATIONAL TAX DEFERRAL CHANGES, MEDICAL DEVICE TAX AND THERAPEUTIC TAX CREDIT HR 3200: AMERICA'S AFFORDBALE HEALTH CHOICES ACT OF 2009; INTERNATIONAL TAX DEFERRAL CHANGES, MEDICAL DEVICE TAX AND THERAPEUTIC TAX CREDIT RESEARCH AND DEVELOPMENT TAX CREDIT--ISSUES RELATED TO CREDIT EXTENSION (NO BILL NUMBER YET ASSIGNED)
S 1796: AMERICA'S HEALTHY FUTURE ACT OF 2009; FOLLOW ON BIOLOGICS, PUBLIC HEALTH FUNDING, COMPARATIVE EFFECTIVENESS RESEARCH AND TAX PROVISIONS HR 3200: AMERICA'S AFFORDBALE HEALTH CHOICES ACT OF 2009; FOLLOW ON BIOLOGICS, PUBLIC HEALTH FUNDING, COMPARATIVE EFFECTIVENESS RESEARCH AND TAX PROVISIONS
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2009 · third_quarter · Q3
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING; HR 3293/SENATE REPORT 111-066: MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING; HR 2892/S 1298: FISCAL YEAR 2010 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT OF 2009; BIOSURVEILLANCE PROGRAMS; HR 2346: SUPPLEMENTAL APPROPRIATIONS ACT, 2009; PANDEMIC FLU FUNDING, CONTINGENCY FUND DRAWS; HR 2996: DEPARTMENT OF THE INTERIOR, ENVIRONMENT AND RELATED AGENCIES APPROPRIATIONS ACT, 2010; COMPUTATIONAL TOXICOLOGY PROGRAM HR 3293/SENATE REPORT 111-066: MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2009 · second_quarter · Q2
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING AND COMPARATIVE EFFECTIVENESS; NET OPERATING LOSS TAX PROVISIONS; FISCAL YEAR 2010 LABOR, HEALTH AND HUMAN SERVICES APPROPRIATIONS: BILL NOT YET INTRODUCED; NATIONAL INSTITUTES OF HEALTH FUNDING; HR 2892 FISCAL YEAR 2010 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT OF 2009; BIOSURVEILLANCE PROGRAMS; HR 2346 S 1054 SUPPLEMENTAL FISCAL YEAR 2009 APPROPRIATIONS; PANDEMIC FLU FUNDING HR 2996 FISCAL YEAR 2010 ENVIRONMENTAL PROTECTION AGENCY APPROPRIATIONS; FUNDING FOR THE EPA COMPUTATIONAL TOXICOLOGY PROGRAM
TAX DEFERRAL; BILL NOT YET INTRODUCED
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2009 · first_quarter · Q1
HR 1260/S 515: PATENT REFORM ACT OF 2009; DAMAGES; POST GRANT; PATENT AND TRADEMARK OFFICE REFORMS; INEQUITBALE CONDUCT
HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT, 2009; NATIONAL INSTITUTES OF HEALTH FUNDING, COMPARATIVE EFFECTIVENESS; NET OPERATING LOSSES TAX PROVISIONS HR 1548: PATHWAY FOR BIOSIMILARS ACT; CREATING A PATHWAY FOR BIOSIMILARS INCLUDING CLINICAL TESTING; NO MANDATORY SUBSTITUTION AT PHARMACY; NEED FOR DIFFERENT NAMES BILL NOT YET INTRODUCED: GENOMICS AND PERSONALIZED MEDICINE ACT; INCENTIVES FOR PERSONALIZED MEDICINE
HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT, 2009; NATIONAL INSTITUTES OF HEALTH FUNDING, COMPARATIVE EFFECTIVENESS; NET OPERATING LOSS TAX PROVISIONS BILL NOT YET INTRODUCED: JUSTICE DEPARTMENT APPROPRIATIONS ACT; FUNDING FOR THE DEBBIE SMITH REAUTHORIZATION ACT OF 2008 HR 1105: APPROPRIATIONS ACT, 2009; NATIONAL INSTITUTES OF HEALTH FUNDING; BIODEFENSE FUNDING
LIFE TECHNOLOGIES CORPORATION via LIFE TECHNOLOGIES CORPORATION
2009 · first_quarter · RR
MEDICAL AND GENETIC RESEARCH POLICY AND FUNDING; BIODEFENCE POLICY AND FUNDING; INTELLECTUAL PROPERTY; ANIMAL AND FOOD SAFETY TESTING
MEDICAL AND GENETIC RESEARCH POLICY AND FUNDING; BIODEFENCE POLICY AND FUNDING; INTELLECTUAL PROPERTY; ANIMAL AND FOOD SAFETY TESTING
MEDICAL AND GENETIC RESEARCH POLICY AND FUNDING; BIODEFENCE POLICY AND FUNDING; INTELLECTUAL PROPERTY; ANIMAL AND FOOD SAFETY TESTING
H.R. 5855: Department of Homeland Security Appropriations Act of 2013; Provisions regarding DNA testing requirements.
H.R.6014/S.517/S. 250: Katie Sepich Enhanced DNA Collection Act of 2012 and Justice for All Reauthorization Act of 2012; All provisions of the bills; Katie Sepich Act amendment to S. 250. H.R. 6628/S. 3250: Sexual Assault Forensic Evidence Registry (SAFER) Act of 2012; Provisions regarding DNA testing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
H.R.601/S.517/S. 250: Katie Sepich Enhanced DNA Collection Act of 2012 and Justice for All Reauthorization Act of 2012; All provisions of the bills; Katie Sepich Act amendment to S. 250.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.988/S.517and revision not yet numbered: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
BETTER Care Act (No Bill number to date); Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.1249/S.23: America Invents Act; Provisions regarding false markings, virtual marking first to file, post grant review, and inequitable conduct. H.R.1056: Patent Continuing Disclosure Act; All provisions.
H.R.988/ S.517: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.1260/S.515: Patent Reform Act of 2009; Senate Managers Amendment; Provisions regarding damages, inequitable conduct, research use exemption, post grant review and false markings. H.R.4954: To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings; Provisions regarding false markings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 5116: America COMPETES Reauthorization Act of 2010; Provisions regarding NIST and synthetic biology.
HR 4213: American Jobs and Closing Tax Loopholes Act of 2010; Provisions regarding research and development tax credits and international tax code changes.
HR 1260/S 515: Patent Reform Act of 2009; Senate Managers Amendment; Provisions regarding damages, inequitable conduct, research use exemption, post grant review and false markings. HR 4954: To amend title 35, United States Code, to provide recourse under the patent law for persons who suffer competitive injury as a result of false markings; Provisions regarding false markings.
S 1649/HR 5057: Weapons of Mass Destruction Prevention and Preparedness Act of 2010; Provisions regarding biosecurity.
HR 4614: Katie Sepich Enhanced DNA Collection Act of 2010; Forensic DNA policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 1260/S 515: PATENT REFORM ACT OF 2009; SENATE MANAGERS AMENDMENT; PROVISIONS REGARDING DAMAGES, INEQUITABLE CONDUCT, RESEARCH USE EXEMPTION AND POST GRANT REVIEW.
HR 4614: KATIE SEPICH ENHANCED DNA COLLECTION ACT OF 2010; FORENSIC DNA POLICY.
HR 3590: PATIENT PROTECTION AND AFFORDABLE CARE ACT / HR 3962: AFFORDABLE HEALTH CARE FOR AMERICA ACT / HR 4872: HEALTH CARE AND EDUCATION RECONCILIATION ACT OF 2010; PROVISIONS REGARDING FOLLOW ON BIOLOGICS, PUBLIC HEALTH FUNDING AND COMPARATIVE EFFECTIVENESS RESEARCH.
S 1649: WEAPONS OF MASS DESTRUCTION PREVENTION AND PREPAREDNESS ACT OF 2009; PROVISIONS REGARDING BIOSECURITY.
RESTORING AMERICAN FINANCIAL STABILITY ACT OF 2009; PROVISIONS REGARDING CORPORATE GOVERNANCE (NO BILL NUMBER YET ASSIGNED).
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
HR 1260/S 515: PATENT REFORM ACT OF 2009; DAMAGES, INEQUITABLE CONDUCT, RESEARCH USE EXEMPTION
S. 2736 & HR 4114: JUSTICE FOR SURVIVORS OF SEXUAL ASSAULTS ACT OF 2009; RAPE KIT BACKLOGS ISSUES H2847/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): DEBBIE SMITH DNA FUNDING DNA TESTING LEGISLATION (NO BILL NUMBER YET ASSIGNED)
HR 2892/S 1298: FISCAL YEAR 2010 DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT OF 2009; BIOSURVEILLANCE PROGRAMS; FISCAL YEAR 2011 ADMINISTRATION'S BUDGET REQUEST FOR NATIONAL INSTITUTES OF HEALTH; NATIONAL INSTITUTES OF HEALTH FUNDING (NO BILL YET INTRODUCED) HR 3293/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING; PANDEMIC FLU SURVEILLANCE H2847/SENATE REPORT 111-066/HR 3288 (CONSOLIDATED APPROPRIATIONS): DEBBIE SMITH DNA FUNDING
HR 2892/S 1298: DEPARTMENT OF HOMELAND SECURITY APPROPRIATIONS ACT, 2010; BIOSURVEILLANCE PROGRAMS S 1649: WEAPONS OF MASS DESTRUCTION PREVENTION AND PREPAREDNESS ACT OF 2009; BIO SECURITY PROVISIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 1260/S 515: PATENT REFORM ACT OF 2009; DAMAGES, INEQUITABLE CONDUCT, RESEARCH USE
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING; AMERICA'S HEALTHY FUTURE ACT OF 2009: BILL NUMBER NOT YET ASSIGNED; FOLLOW ON BIOLOGICS; HR 3200: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009; FOLLOW ON BIOLOGICS HR 3293/SENATE REPORT 111-066: MAKING APPROPRIATIONS FOR THE DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2010, AND FOR OTHER PURPOSES; NATIONAL INSTITUTES OF HEALTH FUNDING
AMERICA'S HEALTHY FUTURE ACT OF 2009: BILL NUMBER NOT YET ASSIGNED; INTERNATIONAL TAX DEFERRAL CHANGES; HR 3200: AMERICA'S AFFORDABLE HEALTH CHOICES ACT OF 2009; INTERNATIONAL TAX DEFERRAL CHANGES RESEARCH AND DEVELOPMENT TAX CREDIT--ISSUES RELATED TO CREDIT EXTENSION
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HR 1260/S 515 PATENT REFORM ACT OF 2009; DAMAGES, POST GRANT, PATENT AND TRADEMARK OFFICE REFORMS; INEQUITABLE CONDUCT
IMPLEMENTATION OF HR 1: AMERICAN RECOVERY AND REINVESTMENT ACT; NATIONAL INSTITUTES OF HEALTH FUNDING AND COMPARATIVE EFFECTIVENESS; NET OPERATING LOSS TAX PROVISIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICAL AND GENETIC RESEARCH POLICY AND FUNDING; BIODEFENCE POLICY AND FUNDING; INTELLECTUAL PROPERTY; ANIMAL AND FOOD SAFETY TESTING
MEDICAL AND GENETIC RESEARCH POLICY AND FUNDING; BIODEFENCE POLICY AND FUNDING; INTELLECTUAL PROPERTY; ANIMAL AND FOOD SAFETY TESTING
MEDICAL AND GENETIC RESEARCH POLICY AND FUNDING; BIODEFENCE POLICY AND FUNDING; INTELLECTUAL PROPERTY; ANIMAL AND FOOD SAFETY TESTING